Tyra Biosciences announced initial results from a Phase 2 trial of its cancer drug dabogratinib, revealing significant Grade 3 adverse events in patients. Following this, the company's stock fell nearly 18%. Pomerantz LLP is investigating whether Tyra and its executives engaged in securities fraud or unlawful practices related to the trial data disclosure. Investors affected by the stock drop are advised to contact the law firm for potential class action participation.
Tyra Biosciences is the subject of an investor investigation following adverse trial results. For readers following the health sector, here is Pluang's market snapshot as of Sep 17, 2026 19:42 WIB: 74 of 91 health-sector stocks rose today. Notable movers include Twist Bioscience Corp at USD 148.47 with a 3.77% increase, AbCellera Biologics Inc at USD 12.07 up 3.43%, and Ascendis Pharma A/S at USD 239.50 down 3.31%.
Evaxion, a clinical-stage TechBio company, has released its financial calendar for 2027, outlining important dates for business updates and financial results. Key events include the full year 2026 results on March 4, the Annual General Meeting on Apr...
CollPlant Biotechnologies will change its Nasdaq ticker from CLGN to OPHI starting November 13, 2026, reflecting its strategic shift toward photonic computing through its subsidiary LightSolver. This move highlights CollPlant's focus on developing Li...
Glider has introduced a global investing platform for tokenized stocks that operates permissionlessly, bypassing the SEC's Tokenized Securities Venues (TSVs) which 50 public companies recently rejected. Backed by major investors like a16z and Coinbas...
BofA Securities raised its price target for Royal Caribbean Group to $365, citing strong booking volumes and the company’s goal of adjusted earnings per share around $20 by 2027. The cruise operator expects 4.5% capacity growth next year and has repo...
Tilray Brands announced that its subsidiaries 10 Barrel Brewing, Widmer Brothers Brewing, and Hop Valley Brewing are now the official craft beer partners of the Portland Trail Blazers. This partnership expands the availability of Oregon craft beers a...
